The number of people with susceptibility test result for rifampicin in Nicaragua
Nicaragua: The number of people with susceptibility test result for rifampicin was 46.72 in 2021. ▲ Rising
Latest (2021)
46.72
Change on year
down 51.2%
World rank
117th
of 146 countries
All-time high
95.75
in 2020
All-time low
24.89
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Nicaragua, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Nicaragua recorded 46.72 for the number of people with susceptibility test result for rifampicin in 2021.
That represents a change of down 51.2% on the previous year and up 87.7% over five years.
Nicaragua ranks 117th of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Nicaragua, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 24.89 | — |
| 2018 | 68.89 | +176.8% |
| 2019 | 38.72 | -43.8% |
| 2020 | 95.75 | +147.3% |
| 2021 | 46.72 | -51.2% |
Nicaragua compared with similar countries
- Nicaragua's 46.72 is below the median for lower middle income countries, which is 78.77, 59% of the median. (32 countries reporting)
- Nicaragua's 46.72 is below the median for Latin America & Caribbean, which is 59.38, 79% of the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 44.17 | 24.89 | 68.89 | 3 |
| 2020s | 71.24 | 46.72 | 95.75 | 2 |
Countries ranked near Nicaragua
More health data for Nicaragua
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6599 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,175 deaths per 1,000 people (2090)
- Number of infants who die before age 1 215 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.3497 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0458 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.323 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Nicaragua?
- The number of people with susceptibility test result for rifampicin in Nicaragua was 46.72 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Nicaragua?
- The highest recorded value was 95.75 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Nicaragua?
- The lowest recorded value was 24.89 in 2017.
- How does Nicaragua rank for the number of people with susceptibility test result for rifampicin?
- Nicaragua ranks 117th out of 146 countries with data for 2021.
- Where does this Nicaragua data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).